Peptide questions · Cagrilintide

How long does cagrilintide take to work?

Reviewed Evidence: EstablishedPublished by PepVault

Cagrilintide’s onset is days–2 weeks, its peak effect comes at 26–68 weeks (trial endpoints), and its typical duration is ongoing, by the library’s timeline (backed by moderate evidence).

The timeline’s basis: Phase 2 dose-finding RCT (Lau 2021), the cagrilintide-only arm of phase 3 REDEFINE 1 (Garvey 2025) and phase 1b PK (Enebo 2021); the trial escalation is from the phase 2 CagriSema protocol (NCT04982575). Not approved on its own.

Cagrilintide week by week

The library places five of its research notes on cagrilintide on the days they cover, from day 1 to day 364 and on: 5 on randomized trials.

Day 1 is the first day of a run. Each bar is one of the library’s research notes, placed on the days it covers.

The cagrilintide notes by day
WhenThe noteEvidence
Days 1–28 (weeks 1–4)The 0.25 mg startRandomized trial
Days 29–364 (weeks 5–52)0.5 mg, the second stepRandomized trial
Days 57–364 (weeks 9–52)1 mg, the middle stepRandomized trial
Days 85–364 (weeks 13–52)1.7 mg, the step before 2.4 mgRandomized trial
From day 113 on2.4 mg, the phase 3 doseRandomized trial
A smiling man in a grey t-shirt in his living room, holding his phone

Model. Individual results vary.

PepVault for iPhone

Track cagrilintide in PepVault

Log each dose and your weekly check-ins, and see your own weeks add up.

Download on the App Store

7 days free on the yearly plan for new subscribers.

The cagrilintide timeline’s milestones

The library’s timeline for cagrilintide marks 6 points from week 1 to week 68, backed by moderate evidence overall.

  • Week 1: Commonly reported: fullness arriving a little sooner in meals
  • Week 4: Trial step from 0.25 to 0.5 mg, after 4 weeks on the start dose
  • Week 8: Commonly reported: smaller portions and less grazing between meals
  • Week 16: The trials reach 2.4 mg here, after four 4-week steps
  • Week 26: Where its phase 2 trial measured weight change
  • Week 68: Where REDEFINE 1 measured its cagrilintide-only arm

The weeks are the library’s reference timeline from studies and reported use, not a promise of what any one person will notice.

Why cagrilintide takes that long

Cagrilintide’s half-life is about 7 days (168 hours), so one dose is about 96.9% cleared after 35 days.

On its schedule (Weekly) the doses overlap, and the level of cagrilintide keeps climbing for about 28–35 days before it levels off, so the first 28–35 days run below the level the later weeks hold.

The notes on cagrilintide follow the trials’ dose steps, 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg, so the later weeks also describe higher steps than the first ones; these are steps from studies, not a schedule for a person.

Cagrilintide against other metabolic & GLP-1 compounds

The library holds an onset-and-peak timeline for 21 metabolic & GLP-1 compounds, cagrilintide among them; 15 of the others share its onset of days–2 weeks.

When metabolic & GLP-1 compounds start to act and peak, by the library’s timelines
CompoundOnsetPeak effect
SemaglutideDays–2 weeks60–68 weeks
TirzepatideDays–2 weeks72+ weeks
RetatrutideDays–2 weeks48+ weeks
DulaglutideDays–2 weeks24–52 weeks (glucose)
ExenatideFirst dose (after-meal glucose)24–30 weeks (HbA1c)
Setmelanotide1–2 weeks (hunger)52 weeks (BMI)
OrforglipronDays–2 weeks72 weeks (trial endpoint)
SurvodutideDays–2 weeks76 weeks (trial endpoint)
MazdutideDays–2 weeks48–60 weeks
PemvidutideDays–2 weeks48+ weeks
CagrilintideDays–2 weeks26–68 weeks (trial endpoints)
PramlintideFirst meal (fullness, after-meal glucose)16–52 weeks (weight, HbA1c)
CagriSemaDays–2 weeks68+ weeks
EloralintideDays–2 weeks48 weeks (phase 2 endpoint)
PetrelintideDays–2 weeks42 weeks (phase 2, still falling)
AmycretinDays–2 weeks36 weeks (longest trial so far)
VK2735Days–2 weeks78 weeks (phase 3 endpoint, not yet read out)
EnicepatideDays–2 weeks48 weeks (phase 2 endpoint, no plateau)
EcnoglutideDays–2 weeks48 weeks (phase 3, no plateau)
EfinopegdutideWeeks24–52 weeks (trial endpoints)
SLU-PP-332Unknown in peopleUnknown in people

Questions people ask

How long does cagrilintide take to work?

Cagrilintide’s onset is days–2 weeks, its peak effect comes at 26–68 weeks (trial endpoints), and its typical duration is ongoing, by the library’s timeline (backed by moderate evidence).

When does cagrilintide reach its peak effect?

By the library’s timeline, cagrilintide’s peak effect comes at 26–68 weeks (trial endpoints), backed by moderate evidence.

How long is cagrilintide usually run?

The library’s timeline gives cagrilintide’s typical duration as ongoing; its cycle note says: Trials run it continuously: 26 weeks in phase 2, 68 weeks in phase 3.

What does the library say about the first days on cagrilintide?

Its first note on cagrilintide, for days 1–28 (weeks 1–4), is “The 0.25 mg start”, resting on randomized trials.

More on cagrilintide

Track it in the app

PepVault for iPhone

Track cagrilintide in PepVault

Log each dose and your weekly check-ins, and see your own weeks add up.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo